Combined growth hormone and weight loss drug for obese adults without diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether adding a growth hormone injection to a standard weight loss medication (semaglutide) helps adults with obesity who don't have diabetes lose weight more effectively. It aims to see if this combination is safe and works better than semaglutide alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- Your body mass index (BMI) is 28 or higher.
- You have not used semaglutide or any diabetes medication before.
- Your thyroid and male hormone levels are normal (if male).
- You are not planning pregnancy and agree to use effective birth control during the study and for 2 months after.
- You have not had weight changes greater than 5% in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
This trial studies whether semaglutide (a diabetes-type weight-loss injection) helps adults with HIV lose weight. It also checks that it’s safe for people whose HIV is well controlled on regular treatment.
Hear when a new Non-diabetic Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.